» Articles » PMID: 37077857

Not in the Drug, Not in the Brain: Causality in Psychedelic Experiences from an Enactive Perspective

Overview
Journal Front Psychol
Date 2023 Apr 20
PMID 37077857
Authors
Affiliations
Soon will be listed here.
Abstract

Psychedelics are psychoactive substances that receive renewed interest from science and society. Increasing empirical evidence shows that the effects of psychedelics are associated with alterations in biochemical processes, brain activity, and lived experience. Still, how these different levels relate remains subject to debate. The current literature presents two influential views on the relationship between the psychedelic molecule, neural events, and experience: The integration view and the pluralistic view. The main aim of this article is to contribute a promising complementary view by re-evaluating the psychedelic molecule-brain-experience relationship from an enactive perspective. We approach this aim the following main research questions: (1) What is the causal relationship between the psychedelic drug and brain activity? (2) What is the causal relationship between brain activity and the psychedelic experience? In exploring the first research question, we apply the concept of to the In exploring the second research question, we apply the concept of to the . Addressing these two research questions from an enactive position offers a perspective that emphasizes interdependence and circular causality on multiple levels. This enactive perspective not only supports the pluralistic view but enriches it through a principled account of how multi-layered processes come to interact. This renders the enactive view a promising contribution to questions around causality in the therapeutic effects of psychedelics with important implications for psychedelic therapy and psychedelic research.

Citing Articles

Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.

Meling D, Egger K, Aicher H, Jareno Redondo J, Mueller J, Dornbierer J J Psychopharmacol. 2024; 38(10):897-910.

PMID: 39340164 PMC: 11487865. DOI: 10.1177/02698811241282637.


Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience.

Nicholas C, Banks M, Lennertz R, Wenthur C, Krause B, Riedner B Transl Psychiatry. 2024; 14(1):372.

PMID: 39266503 PMC: 11393325. DOI: 10.1038/s41398-024-03059-8.


Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.

Singer B, Meling D, Hirsch-Hoffmann M, Michels L, Kometer M, Smigielski L Sci Rep. 2024; 14(1):7211.

PMID: 38531905 PMC: 10966054. DOI: 10.1038/s41598-024-55726-x.


The Fundamental Tension in Integrated Information Theory 4.0's Realist Idealism.

Cea I, Negro N, Signorelli C Entropy (Basel). 2023; 25(10).

PMID: 37895574 PMC: 10606349. DOI: 10.3390/e25101453.


Commentary: Not in the drug, not in the brain: causality in psychedelic experiences from an enactive perspective.

Cea I Front Psychol. 2023; 14:1217108.

PMID: 37425174 PMC: 10325671. DOI: 10.3389/fpsyg.2023.1217108.

References
1.
Goldberg S, Shechet B, Nicholas C, Ng C, Deole G, Chen Z . Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis. Psychol Med. 2020; 50(16):2655-2666. PMC: 7855004. DOI: 10.1017/S003329172000389X. View

2.
Andersen K, Carhart-Harris R, Nutt D, Erritzoe D . Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatr Scand. 2020; 143(2):101-118. DOI: 10.1111/acps.13249. View

3.
Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer P . Homological scaffolds of brain functional networks. J R Soc Interface. 2014; 11(101):20140873. PMC: 4223908. DOI: 10.1098/rsif.2014.0873. View

4.
Nour M, Carhart-Harris R . Psychedelics and the science of self-experience. Br J Psychiatry. 2017; 210(3):177-179. DOI: 10.1192/bjp.bp.116.194738. View

5.
Kometer M, Vollenweider F . Serotonergic Hallucinogen-Induced Visual Perceptual Alterations. Curr Top Behav Neurosci. 2016; 36:257-282. DOI: 10.1007/7854_2016_461. View